Home
NeuroDerm

NeuroDerm Market Share Analysis for August 2026

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.

Health > Biotechnology and Pharmaceuticals

Domainneuroderm.com

Year Founded2003

Employees51 - 200

Annual Revenue$5M - $10M

NeuroDerm

NeuroDerm (including company regionals)

neuroderm.com

See more website traffic and engagement information

NeuroDerm Revenue up to August 2026 is 5M - 10M

revenue generated by NeuroDerm top domains

NeuroDerm top domains revenue over 3 years

Revenue for NeuroDerm top domains

neuroderm.com5M - 10M

See more with Sales Intelligence

Total visits to NeuroDerm's top domains

Understand NeuroDerm market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neuroderm.com4.1K

See more with Sales Intelligence

Avg. visit duration in NeuroDerm's top domains

Analyze NeuroDerm engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neuroderm.com00:00:06

See more with Sales Intelligence

Avg. pageviews on NeuroDerm's top domains

See how NeuroDerm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neuroderm.com1.51

See more with Sales Intelligence

NeuroDerm top competitors by domain

Top similar sites in August 2026, ranked by their affinity

biocentury.comCompany NameBioCenturyEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$15M - $25MTotal visits34.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by NeuroDerm

These are the website technologies, by industry, used by NeuroDerm top domains

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from NeuroDerm

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeuroDerm Ltd. is developing central nervous system product candidates.NeuroDerm Ltd. is an integrated pharmaceutical and medical technology company developing central nervous system (CNS) product candidates.

NewsMitsubishi Tanabe Pharma Europe Ltd acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.Dr. Yaar is a serial entrepreneur, who served as founder and former CEO at Neuroderm, an Israeli pharmaceutical company acquired by Mitsubishi Tanabe Pharma in 2017 for $1.1 billion.

NewsMitsubishi Tanabe Pharma America, Inc. acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.NeuroDerm Ltd. (Nasdaq: NDRM ), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced acquisition of NeuroDerm by Mitsubishi Tanabe Pharma Corporation (TSE Code: 4508), a publicly traded company on the Tokyo Stock Exchange (“MTPC”).